15
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Follow-up of Minimal Residual Disease in Pediatric Acute Myeloblastic Leukemia Using Metaphase-FISH

, , , &
Pages 1261-1265 | Published online: 09 Jun 2011

References

  • Foroni, L.. Harrison. C.J., Hoffbrand. A.V. and Potter. M.N. (1999) "investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis". British Journal of Haematology 1.05, 7–24.
  • Liu Yin. I.A. and Tobal. K. (1999) -Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance". British Journal of imern,m,mgy 106. 578–590.
  • Morschhauser. E. Cayucla. J.M., Martini. S. Barachol. A.. Roussekn, P., Sock. 0„ Berthou, P.. Joule,Stracunans, N..Sigaux. F., Fenaux. P. and Preudhomme. C. (2000) "Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in 1(821) acute myeloid leukemia: a multicenter study of 51 patients". Journal of Clinical Oncology 18,788–.794.
  • Tubal. K„ Newton, J., Machetn, M.. Chang. J., Morgenstern, a. Evans.Morgan, G., Lucas, GS. and Yin. J.A.L. (2000)"Molecular quantitation of minimal residual disease in acute myeloid leukemia with 08:21) can identity patients in durable remission and predict clinical relapse". Blood 95. 8115–819.
  • San Miguel, J.F.. Martinez. A.,141acedo. A.. Vidriales. M.B. Lopez-Barges, C., Grum'lez. K. Caballero, D.. Garcia-Marcos. MA.. Ramos, F., Fernandes-Calvo. J.. Calmunti a, MI., Diaz-Madiavilla. J. and Orfao, A. (1997) "Imrnunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients". Blood 90, 2465–2470.
  • Engel, H., Goudacre. A.. Keyhani. A.. Jiang, S.. Van. Ni'., M.. Sanchez-Williams, G. and Andreeff., M. (1997) "Minimal residual disease in acute myelogenous leukaemia and myelodys-plastic syndromes: a follow-up of patients in clinical remission". British Journal Of Haematology 99, 64–75.
  • El-Rifai, W.E,, Ruutti. T.. Molten, E.. Volin. L. and Knuutila. S. (1997) 'Prognostic value of metaphase-fluorescencc in situ hybridization in follow-up of patients with acute myeloid leukemia in remission", Blood 89. 3330–3334,
  • Vendiui. A.. Buccisano. E. Del Poeta, 0-, Maurillo. L., Tamburini, A., Cox. C., Battaglia. A„ Catalano. O.. Del Moro. B.. Cudillo, L., Fostoria°. M., Masi, M. and Amadori, S. (2000) "Level of mirtitnal residual disease alla consolidation therapy predicts outcome in acute myeloid leukemia". Blood 96, 3948–3952.
  • El-Rifai. W.E., Ruutu, T., Vettenninut, K., Elonen, E., Saarinen. U.. Voila, L. and Knuutila, S. (1997) "Follow-up of residual disease using metaphae-FISH in patients with acute lymphoblastic leukemia in remission". Leukemia 11, 633-63E1
  • W.E.. RuuW. T., Vettenranta, K.. Temtamy. S. andKnuutila, S. (1996) -Minimal residual disease after allogeneic hone marrow transplantation for chronic myeloid leukaemia; a metaphase-FISH study". British Journal of Haematology 92, 365-369_
  • Huhta, T., Vettenranta, K. Heinonen, K., Kanerva, .1.. Larramendy. M.L.. Maitiamaki, E.. Saarinen-PihkaJa. U.M. and Knuutila. S. (1999) "Comparative genomic hybridization and conventional eylogenetic analyses in childhood acute myeloid leukemia" Leukemia and Lymphoma 35, 311-3 l5.
  • Knuutila, S. (1997) "Lineage specificity in haernatological neoplasms", British Journal of Haematology 96, 2–11.
  • Montagna, D., Arica, M., Montini, E.. De Benedetti, F. and Maccario, R. (1993) 'Identification of HLA-unrestricted CI38+/CD8cytowitic T-eoll clones specific fur leukemia blastsin children with acute leukemia", Cancer Research 55, 3835 3839.
  • Bradstock, K. and Gottlieb. Di. (1995) "Interaction of acute leukemia cells with the bone marrow microenvironment: impli-cations for control of minimal residual disease". Leukemia and Lymphoma 111. 1–16.
  • Cleaves. M. (1997) "Silence of the leukemic clone". New igland Journal of Medicine 336, 367 369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.